FINWIRES · TerminalLIVE
FINWIRES

Wix.com's Lowered Forecast Reinforces View of AI Headwinds Hitting Web Design Space, RBC Says

By

Wix.com's (WIX) lowered forecast for Q2 and 2026 reinforces the view that artificial intelligence headwinds are hitting the web design space, RBC Capital Markets said in a Tuesday research note.

With the company lowering its revenue guidance for Q2 and 2026 to low/mid-teens from mid-teens growth on account of incremental weakness in the partner business, RBC said that this seems to be a case of the partners' own business headwinds versus displacing Wix's tools with AI-native alternatives.

Even as Wix.com maintained its free cash flow margin outlook of high-teens, aided by a 20% headcount reduction, RBC said it struggles to see a path to stabilization given the cross currents and competitive landscape.

RBC lowered its price target on the company to $45 from $60 and maintained its sector perform rating.

Price: $48.82, Change: $+0.60, Percent Change: +1.25%

Related Articles

Wire

Mission Produce Fiscal Q2 Adjusted Earnings, Revenue Fall; Shares Drop After Hours

Mission Produce (AVO) reported fiscal Q2 non-GAAP net income late Monday of $0.01 per diluted share, down from $0.12 a year earlier.Three analysts polled by FactSet expected $0.05.Revenue in the three months ended April 30 fell to $290.9 million from $380.3 million a year earlier.Three analysts expected $256.3 million.The board approved a stock repurchase program of up to $100 million over the next 36 months.The company's shares fell 5.9% in after-hours trading.

$AVO
Wire

Mama's Creations Fiscal Q1 Earnings, Revenue Rise

Mama's Creations (MAMA) reported fiscal Q1 earnings late Monday of $0.05 per diluted share, up from $0.03 a year earlier.Analysts polled by FactSet expected $0.03.Revenue in the three months ended April 30 rose to $52.8 million from $35.3 million a year earlier.Analysts expected $51.6 million.The company's shares fell 2.6% in after-hours trading.

$MAMA
Wire

Tango Therapeutics Launches $500 Million Stock Offering

Tango Therapeutics (TNGX) said Monday it is launching $500 million underwritten public offering of common stock.All shares are offered by the company, according to a statement.Tango said it will grant underwriters a 30-day option to purchase up to an additional $75 million of shares.

$TNGX